Why is Shanghai Fudan Forward S&T Co., Ltd. ?
- Poor long term growth as Net Sales has grown by an annual rate of -8.49% and Operating profit at -268.38% over the last 5 years
- The company is Net-Debt Free
- The company has declared negative results for the last 3 consecutive quarters
- NET PROFIT(HY) At CNY -26.04 MM has Grown at -265.97%
- INTEREST(HY) At CNY 7.37 MM has Grown at 12.42%
- OPERATING CASH FLOW(Y) Lowest at CNY -64.4 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -37.23%, its profits have fallen by -55.9%
- Even though the market (China Shanghai Composite) has generated returns of 3.40% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -37.23% returns
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shanghai Fudan Forward S&T Co., Ltd. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 6.34 times
At CNY -14.81 MM has Grown at 69.64%
At CNY -15.1 MM has Grown at 69.83%
At CNY -26.04 MM has Grown at -265.97%
At CNY 7.37 MM has Grown at 12.42%
Lowest at CNY -64.4 MM
Lowest at -41.75%
Grown by 11.25% (YoY
Lowest at CNY 272.61 MM
Highest at 95.11 %
Lowest at CNY 131.54 MM
Here's what is working for Shanghai Fudan Forward S&T Co., Ltd.
Pre-Tax Profit (CNY MM)
Net Profit (CNY MM)
Debtors Turnover Ratio
Here's what is not working for Shanghai Fudan Forward S&T Co., Ltd.
Net Sales (CNY MM)
Interest Paid (CNY MM)
Operating Cash Flows (CNY MM)
Net Sales (CNY MM)
Cash and Cash Equivalents
Debt-Equity Ratio
Raw Material Cost as a percentage of Sales






